ribavirin has been researched along with Porphyria Cutanea Tarda in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 7 (87.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azim, J; McCurdy, H; Moseley, RH | 1 |
| Hoffman, CJ; Ray, SC | 1 |
| Cacoub, P | 1 |
| Duclos-Vallée, JC | 1 |
| Christiansen, L; Der-Petrossian, M; Ferenci, P; Gangl, A; Jessner, W; Maier, H; Steindl-Munda, P | 1 |
| Bachmeyer, C; Cadranel, JF; Ducamp-Posak, I; Dumouchel, P; Hammi, R; Thevenot, T | 1 |
| Alessio, A; Buonsante, ME; Frider, B; Pellerano, G; Tiscornia, J | 1 |
| Sharara, AI | 1 |
3 review(s) available for ribavirin and Porphyria Cutanea Tarda
| Article | Year |
|---|---|
[Treatment of extrahepatic manifestations associated with hepatitis C virus infection].
Topics: Antiviral Agents; Autoantibodies; Cryoglobulinemia; Drug Therapy, Combination; Fatigue; Female; Glomerulonephritis, Membranoproliferative; Hepatitis C; Hepatitis C, Chronic; Humans; Interferons; Lymphoproliferative Disorders; Male; Middle Aged; Odds Ratio; Porphyria Cutanea Tarda; Pruritus; Ribavirin; Sjogren's Syndrome; Surveys and Questionnaires; Thrombocytopenia; Time Factors; Vascular Diseases | 2002 |
[Treatment of hepatitis C virus associated extrahepatic manifestations].
Topics: Antiviral Agents; Autoantibodies; Clinical Enzyme Tests; Clinical Trials as Topic; Cryoglobulinemia; Drug Therapy, Combination; Glomerulonephritis, Membranoproliferative; Hepatitis C; Humans; Interferons; Lichen Planus; Lymphoma, Non-Hodgkin; Porphyria Cutanea Tarda; Prospective Studies; Purpura, Thrombocytopenic; Retrospective Studies; Ribavirin; Sjogren's Syndrome; Thyroid Diseases; Time Factors; Transaminases | 2002 |
Chronic hepatitis C.
Topics: Antiviral Agents; Blood Transfusion; Carcinoma, Hepatocellular; Cryoglobulinemia; Disease Progression; Forecasting; Genotype; Glomerulonephritis, Membranoproliferative; Hepacivirus; Hepatitis C; Hepatitis, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Porphyria Cutanea Tarda; Ribavirin; Risk Factors; Treatment Outcome | 1997 |
5 other study(ies) available for ribavirin and Porphyria Cutanea Tarda
| Article | Year |
|---|---|
Porphyria cutanea tarda as a complication of therapy for chronic hepatitis C.
Topics: Anemia, Hemolytic; Antiviral Agents; Drug Therapy, Combination; Hemochromatosis; Hemochromatosis Protein; Hepatitis C, Chronic; Histocompatibility Antigens Class I; Humans; Interferon alpha-2; Interferon-alpha; Iron Overload; Male; Membrane Proteins; Middle Aged; Mutation; Phlebotomy; Polyethylene Glycols; Porphyria Cutanea Tarda; Recombinant Proteins; Ribavirin | 2008 |
Severe pruritus after completing pegylated interferon for hepatitis C.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hand; Hepatitis C; HIV Infections; Humans; Interferons; Middle Aged; Polyethylene Glycols; Porphyria Cutanea Tarda; Pruritus; Ribavirin; Severity of Illness Index; Time Factors | 2008 |
Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Middle Aged; Porphyria Cutanea Tarda; Ribavirin | 2002 |
Occurrence of porphyria cutanea tarda during peginterferon/ribavirin therapy for chronic viral hepatitis C.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Porphyria Cutanea Tarda; Recombinant Proteins; Ribavirin | 2005 |
[Development of porphyria cutanea tarda in a chronic hepatitis C patient with indetectable viremia under treatment with peg-interferon plus ribavirin].
Topics: Antiviral Agents; Hemochromatosis; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Porphyria Cutanea Tarda; Recombinant Proteins; Ribavirin | 2006 |